Mutational Profile and Prognostic Significance of TP53 in Diffuse Large B-cell Lymphoma Patients Treated with Rituximab-CHOP: A Report From an International DLBCL Rituximab-CHOP Consortium Program Study
暂无分享，去创建一个
W. Choi | J. Winter | K. Dybkær | M. Piris | Y. C. Tai | Wei-min Liu | G. Bhagat | Y. Zu | K. Young | Z. Xu-Monette | L. Medeiros | L. Abruzzo | K. Richards | M. Møller | J. Huh | S. Montes-Moreno | C. Visco | E. Hsi | M. Ponzoni | A. Ferreri | Yong Li | W. Xu | R. Miranda | X. Zhao | A. Chiu | R. Go | W. Ai | A. Tzankov | A. Orazi | B. Kahl | Jianyong Li | Xiaoying Zhao | Qin Huang | Lin Wu | J. Krieken | F. Zhou